Suppr超能文献

一种与erk1和erk2不同的40 kDa髓鞘碱性蛋白激酶在有丝分裂的HeLa细胞中被激活。

A 40-kDa myelin basic protein kinase, distinct from erk1 and erk2, is activated in mitotic HeLa cells.

作者信息

Heider H, Hug C, Lucocq J M

机构信息

Anatomisches Institut, Universität Bern, Switzerland.

出版信息

Eur J Biochem. 1994 Jan 15;219(1-2):513-20. doi: 10.1111/j.1432-1033.1994.tb19966.x.

Abstract

Mitotic HeLa cells showed an increased phosphorylation activity towards myelin basic protein compared to cells in G1 or S phases. Further investigation using renaturation gels revealed that, in mitotic cell lysates, a protein with an apparent molecular mass of around 40 kDa phosphorylates myelin basic protein. This kinase is active early in mitosis, but is then downregulated concomitantly with p34cdc2 kinase as mitosis proceeds, its activity decreasing to basal levels by early G1. The molecular mass of the kinase suggested that it might be one of the human homologues of rat erk1 or erk2. However, antibodies raised against C-terminal sequences of erk1 and erk2 failed to immunoprecipitate renaturable kinase activity from mitotic lysates. In addition, in immunoblots erk1 and erk2 failed to show the well established changes in electrophoretic migration that are consequences of their activation. These data indicate that these two mitogen-activated protein (MAP) kinases are not stimulated during HeLa cell mitosis and indicate that the 40-kDa kinase is either a new member of the MAP kinase family or it is a novel mitotic kinase that has not yet been described.

摘要

与处于G1期或S期的细胞相比,有丝分裂期的HeLa细胞对髓鞘碱性蛋白的磷酸化活性增强。使用复性凝胶进行的进一步研究表明,在有丝分裂期细胞裂解物中,一种表观分子量约为40 kDa的蛋白质可使髓鞘碱性蛋白磷酸化。这种激酶在有丝分裂早期具有活性,但随着有丝分裂的进行,它会与p34cdc2激酶同时被下调,到G1早期其活性降至基础水平。该激酶的分子量表明它可能是大鼠erk1或erk2的人类同源物之一。然而,针对erk1和erk2 C末端序列产生的抗体未能从有丝分裂期裂解物中免疫沉淀出可复性的激酶活性。此外,在免疫印迹中,erk1和erk2并未显示出因激活而导致的电泳迁移率的典型变化。这些数据表明,这两种丝裂原活化蛋白(MAP)激酶在HeLa细胞有丝分裂期间未被激活,这表明40 kDa激酶要么是MAP激酶家族的新成员,要么是一种尚未被描述的新型有丝分裂激酶。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验